Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2003
10/23/2003WO2003087381A1 Expression system of actinomycete-origin cytochrome p-450 in escherichia coli
10/23/2003WO2003087380A1 Derivatives of the nf-kappab inducing enzyme, their preparation and use
10/23/2003WO2003087378A1 Nucleic acid immunization
10/23/2003WO2003087377A1 Insecticide proteins from photorabdus luminescens
10/23/2003WO2003087375A1 Cartilage differentiation regulating gene
10/23/2003WO2003087374A1 Derivatives of the il-2 receptor gamma chain, their production and use.
10/23/2003WO2003087373A2 Production of recombinant fragments of muscle acetylcholine receptor and their use for ex vivo immunoadsorption of anti-ach receptor antibodies from myasthenic patients
10/23/2003WO2003087372A2 Growth factor derived from hepatome and the use of the same
10/23/2003WO2003087364A1 Novel g protein-coupled receptor and its gene
10/23/2003WO2003087363A1 Cancer-associated gene mina 53, protein mina 53 and monoclonal antibody thereof
10/23/2003WO2003087362A1 Novel g protein-coupled receptor gene and protein bg8
10/23/2003WO2003087359A1 Phox2b polymorphisms as hirschsprung's disease diagnostic markers and methods based thereon
10/23/2003WO2003087357A2 Nucleic acid comprising retinal-specific regulatory region
10/23/2003WO2003087356A2 Helicokinin-receptor from insects
10/23/2003WO2003087355A1 Inactivation resistant factor viii
10/23/2003WO2003087351A1 Hepatitis b viral variants with redused susceptibility to nucleoside analogs and uses thereof
10/23/2003WO2003087348A1 Packaging cell line for diphtheria toxin expressing non-replicating adenovirus
10/23/2003WO2003087343A1 Production of stable collagens
10/23/2003WO2003087340A2 Antibodies that bind to integrin alpha-v-beta-6 and methods of use thereof
10/23/2003WO2003087338A2 Her-2 receptor tyrosine kinase molecules and uses thereof
10/23/2003WO2003087337A2 Vascularized human skin equivalent
10/23/2003WO2003087331A2 Polyvalent cation-sensing receptor in atlantic salmon
10/23/2003WO2003087321A2 Plant acyl-coa synthetases
10/23/2003WO2003087320A2 Antagonists of il-21 and modulation of il-21-mediated t cell responses
10/23/2003WO2003087319A2 Carcinoembryonic antigen cell adhesion molecule 1 (ceacam1) structure and uses thereof in drug identification and screening
10/23/2003WO2003087318A2 Truncated 24 kda basic fibroblast growth factor
10/23/2003WO2003087313A2 Enhanced silk exsertion under stress
10/23/2003WO2003087311A2 PrLZ REGULATORY ELEMENTS IN THE TREATMENT OF DISEASE AND THE DISCOVERY OF THERAPEUTICS
10/23/2003WO2003087309A2 Bdnf polymorphisms and association with bipolar disorder
10/23/2003WO2003087308A2 Use of interleukin-24 to treat ovarian cancer
10/23/2003WO2003087306A2 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer
10/23/2003WO2003087305A2 Methods and compositions for anchoring stem cells in a microenvironment
10/23/2003WO2003087300A2 Secreted proteins
10/23/2003WO2003087299A2 Methods of characterizing molecular interaction sites on proteins
10/23/2003WO2003087289A2 Methods for the selection of compounds useful for the treatment of huntington’s disease
10/23/2003WO2003087197A1 Hydrogel with controllable mechanical chemical and biological properties and method for making same
10/23/2003WO2003087195A2 Heterogeneous protein networks crosslinked with silicone-containing links, and methods for producing them
10/23/2003WO2003087162A2 Neopeptides and methods useful for detection and treatment of cancer
10/23/2003WO2003087161A1 Modified factor viii
10/23/2003WO2003087160A1 Modification of the properties of a fibrin matrix with respect to growth and ingrowth of cells
10/23/2003WO2003087158A2 Regulation of human transient receptor potential channel
10/23/2003WO2003087157A2 Differentially expressed genes involved in angiogenesis, the proteins encoded thereby, and methods of using the same
10/23/2003WO2003087156A2 Heterogeneous crosslinked protein networks and methods for producing them
10/23/2003WO2003087155A1 Novel protein and dna thereof
10/23/2003WO2003087154A2 Sequences involved in the phenomena of tumour suppression, tumour reversion, apoptosis and/or resistance to viruses, and the use of the same as medicaments
10/23/2003WO2003087153A1 Mouse kruppel-type zinc finger protein knox-25 and the use of thereof
10/23/2003WO2003087152A1 Luminescent markers
10/23/2003WO2003087151A1 A sperm polypeptide
10/23/2003WO2003087150A2 Novel fluorescent proteins containing fqygf in the chromophore
10/23/2003WO2003087149A2 Bacillus licheniformis mutant host cell
10/23/2003WO2003087148A2 Bacillus licheniformis mutant host cell
10/23/2003WO2003087147A1 Stretptococcal genes involved in osmotic and oxidative stress and in virulence
10/23/2003WO2003087146A2 Purified polypeptides from s. aureus, h. pylori and e. coli involved in cellular transport and metabolism
10/23/2003WO2003087145A2 Purified polypeptides involved in quorum sensing
10/23/2003WO2003087144A2 Insecticide proteins from photorabdus luminescens
10/23/2003WO2003087143A2 Human polypeptides having antibacterial activity
10/23/2003WO2003087142A2 Bacillus licheniformis mutant host cell
10/23/2003WO2003087140A1 NON-PRIMATE FXRb AS A LANOSTEROL SENSING NUCLEAR HORMONE RECEPTOR AND RELATED USES
10/23/2003WO2003087139A2 Treatment of gastroparesis
10/23/2003WO2003087138A2 Methods for identifying polypeptide factors interacting with rna
10/23/2003WO2003087137A2 New therapeutic uses of tri-, tetra-, penta-, and polypeptides
10/23/2003WO2003087136A2 Peptides derived from cadherin and methods of use thereof
10/23/2003WO2003087135A2 Novel pheromone receptor
10/23/2003WO2003087134A2 G-protein coupled receptor ligands and methods
10/23/2003WO2003087132A2 Compositions and methods for evaluating and designing nuclear receptor ligands that modulate co-regulator affinity
10/23/2003WO2003087129A2 Immunogenic peptides, and method of identifying same
10/23/2003WO2003087128A2 Secretory signal sequences and uses thereof
10/23/2003WO2003087126A2 Heteroclitic analogs and related methods
10/23/2003WO2003087125A2 A novel g protein-coupled purinergic receptor, gave 17
10/23/2003WO2003087124A2 Hmgn2 peptides and related melecules that selectively home to tumor blood vessels and tumor cells
10/23/2003WO2003087122A2 Sequences involved in the phenomena of tumour suppression, tumour reversion, apoptosis and/or resistance to viruses, and the use of the same as medicaments
10/23/2003WO2003086491A2 Tissue defect dressings comprising a keratin network
10/23/2003WO2003086473A1 Mycoplasma polypeptides
10/23/2003WO2003086470A2 Smac-peptides as therapeutics against cancer and autoimmune diseases
10/23/2003WO2003086459A1 Methods of treatement using ctla-4 antibodies
10/23/2003WO2003086453A1 Purified subfragment codifying for neuroaminidase, recombinant neuroaminidase and its use in zooprophylaxis
10/23/2003WO2003086450A1 Active antiangiogenic therapy
10/23/2003WO2003086449A1 ANTI-INFLAMMATORY AND WOUND HEALING EFFECTS OF LYMPHOID THYMOSIN β 4
10/23/2003WO2003086447A1 Methods for modulating neovascularization
10/23/2003WO2003086446A1 Monomeric and dimeric fluorescent protein variants and methods for making same
10/23/2003WO2003086444A1 Use of transthyretin peptide/protein fusions to increase the serum half-life of pharmacologically active peptides/proteins
10/23/2003WO2003086374A1 Regulation of a novel colon specific retinol dehydrogenase by apc and cdx2
10/23/2003WO2003086326A2 G-type peptides to ameliorate atherosclerosis
10/23/2003WO2003086311A2 Methods for treating tweak-related conditions
10/23/2003WO2003086308A2 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
10/23/2003WO2003086301A2 Antibodies that specifically bind to tr2
10/23/2003WO2003086296A2 Treatment for type 1 diabetes before and after expression of predisposition markers.
10/23/2003WO2003086286A2 Treatment of type 1 diabetes before and after expression of predisposition markers
10/23/2003WO2003086277A2 Attenuated gram negative bacteria
10/23/2003WO2003086276A2 Compositions and methods for portal specific gene delivery and treatment of infection
10/23/2003WO2003086272A2 Ultrapure transferrin for pharmaceutical compositions
10/23/2003WO2003086175A2 Compositions and methods for the therapy and diagnosis of lung cancer
10/23/2003WO2003086174A2 A new method for the diagnosis and prognosis of malignant diseases
10/23/2003WO2003065972A3 Methods for screening osteogenic compounds
10/23/2003WO2003057252A8 Human mast cell-expressed membrane proteins
10/23/2003WO2003055914A3 Modified receptors for the discovery of therapeutic ligands
10/23/2003WO2003055899A3 Oxidized fungal antigens and methods of making and using thereof
10/23/2003WO2003054193A3 Raf/ras binding compounds
10/23/2003WO2003054005A3 Bone polypeptide-1
10/23/2003WO2003053362A3 Systems and methods for treating patients with collagen-rich material extracted from adipose tissue
1 ... 1504 1505 1506 1507 1508 1509 1510 1511 1512 1513 1514 1515 1516 1517 1518 1519 1520 1521 1522 1523 1524 ... 2916